Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A phase II study of erlotinib in combination with capecitabine in previously treated patients with metastatic pancreatic cancer

A phase II study of erlotinib in combination with capecitabine in previously treated patients with metastatic pancreatic cancer. Journal of Clinical Oncology, 2005 ASCO Annual Meeting Proceedings, Part I of II. 2005; 23(16S ):A4099.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.